Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02873962 |
|---|---|
| Brief Title: | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib |
| First Submitted : | August 17, 2016 |
| First Submitted that Met QC Criteria : | August 17, 2016 |
| First Posted : | August 22, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |